TGF-β signalling in tumour associated macrophages

Immunobiology

Volumn 222, Issue 1, 2017, Pages 75-81

  Gratchev, Alexei ^a,b  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^b TOMSK STATE UNIVERSITY   (Russian Federation)

Author keywords

Cancer; Macrophage; Smad; TGFbeta; Tumour associated macrophages

Indexed keywords

ACTIVIN A RECEPTOR TYPE IIA; ACTIVIN A RECEPTOR TYPE IIB; ACTIVIN RECEPTOR LIKE KINASE 1; ACTIVIN RECEPTOR LIKE KINASE 2; ACTIVIN RECEPTOR LIKE KINASE 4; ACTIVIN RECEPTOR LIKE KINASE 7; BONE MORPHOGENETIC PROTEIN RECEPTOR; BONE MORPHOGENETIC PROTEIN RECEPTOR 1A; BONE MORPHOGENETIC PROTEIN RECEPTOR 1B; BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CD109 RECEPTOR; ENDOGLIN; LOX5AP PROTEIN; OLR1 PROTEIN; RECEPTOR; SMAD1 PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD4 PROTEIN; SMAD5 PROTEIN; SMAD6 PROTEIN; SMAD7 PROTEIN; SMAD8 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 3; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TUMOR MARKER; UNCLASSIFIED DRUG; UNINDEXED DRUG; BONE MORPHOGENETIC PROTEIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

GENE OVEREXPRESSION; HUMAN; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TUMOR ASSOCIATED LEUKOCYTE; UPREGULATION; ANIMAL; GENE EXPRESSION; GENETICS; IMMUNOLOGY; METABOLISM; NEOPLASM; PATHOLOGY; TUMOR MICROENVIRONMENT;

ANIMALS; BONE MORPHOGENETIC PROTEINS; GENE EXPRESSION; HUMANS; MACROPHAGES; NEOPLASMS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SMAD PROTEINS; TRANSFORMING GROWTH FACTOR BETA; TUMOR MICROENVIRONMENT;

EID: 84971384305     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2015.11.016     Document Type: Review

References (70)

1. Andersson, O., Reissmann, E., Ibanez, C.F., Growth differentiation factor 11 signals through the transforming growth factor-beta receptor ALK5 to regionalize the anterior-posterior axis. EMBO Rep. 7 (2006), 831–837.
2. Ashcroft, G.S., Bidirectional regulation of macrophage function by TGF-beta. Microbes Infect. 1 (1999), 1275–1282.
3. Assoian, R.K., Fleurdelys, B.E., Stevenson, H.C., Miller, P.J., Madtes, D.K., Raines, E.W., Ross, R., Sporn, M.B., Expression and secretion of type beta transforming growth factor by activated human macrophages. Proc. Nat. Acad. Sci. U. S. A. 84 (1987), 6020–6024.
4. Bakkebo, M., Huse, K., Hilden, V.I., Forfang, L., Myklebust, J.H., Smeland, E.B., Oksvold, M.P., SARA is dispensable for functional TGF-beta signaling. FEBS Lett. 586 (2012), 3367–3372.
5. Barcellos-Hoff, M.H., Derynck, R., Tsang, M.L., Weatherbee, J.A., Transforming growth factor-beta activation in irradiated murine mammary gland. J. Clin. Invest. 93 (1994), 892–899.
6. Bharathy, S., Xie, W., Yingling, J.M., Reiss, M., Cancer-associated transforming growth factor beta type II receptor gene mutant causes activation of bone morphogenic protein-Smads and invasive phenotype. Cancer Res. 68 (2008), 1656–1666.
7. Blanchette, F., Rivard, N., Rudd, P., Grondin, F., Attisano, L., Dubois, C.M., Cross-talk between the p42/p44 MAP kinase and Smad pathways in transforming growth factor beta 1-induced furin gene transactivation. J. Biol. Chem. 276 (2001), 33986–33994.
8. Brandes, M.E., Wakefield, L.M., Wahl, S.M., Modulation of monocyte type I transforming growth factor-beta receptors by inflammatory stimuli. J. Biol. Chem. 266 (1991), 19697–19703.
9. Bruno, E., Horrigan, S.K., Van Den Berg, D., Rozler, E., Fitting, P.R., Moss, S.T., Westbrook, C., Hoffman, R., The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis. Blood 91 (1998), 1917–1923.
10. Chen, Y., Kam, C.S., Liu, F.Q., Liu, Y., Lui, V.C., Lamb, J.R., Tam, P.K., LPS-induced up-regulation of TGF-beta receptor 1 is associated with TNF-alpha expression in human monocyte-derived macrophages. J. Leukocyte Biol. 83 (2008), 1165–1173.
11. Cuenda, A., Rouse, J., Doza, Y.N., Meier, R., Cohen, P., Gallagher, T.F., Young, P.R., Lee, J.C., SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett. 364 (1995), 229–233.
12. Cui, W., Zhou, J., Dehne, N., Brune, B., Hypoxia induces calpain activity and degrades SMAD2 to attenuate TGFbeta signaling in macrophages. Cell Biosci., 5, 2015, 36.
13. Daly, A.C., Randall, R.A., Hill, C.S., Transforming growth factor beta-induced Smad1/5 phosphorylation in epithelial cells is mediated by novel receptor complexes and is essential for anchorage-independent growth. Mol. Cell. Biol. 28 (2008), 6889–6902.
14. Derynck, R., Zhang, Y.E., Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 425 (2003), 577–584.
15. Domagala-Kulawik, J., Osinska, I., Hoser, G., Mechanisms of immune response regulation in lung cancer. Transl. Lung Cancer Res. 3 (2014), 15–22.
16. Finnson, K.W., Parker, W.L., Chi, Y., Hoemann, C.D., Goldring, M.B., Antoniou, J., Philip, A., Endoglin differentially regulates TGF-beta-induced Smad2/3 and Smad1/5 signalling and its expression correlates with extracellular matrix production and cellular differentiation state in human chondrocytes. Osteoarthritis Cartilage 18 (2010), 1518–1527.
17. Gong, D., Shi, W., Yi, S.J., Chen, H., Groffen, J., Heisterkamp, N., TGFbeta signaling plays a critical role in promoting alternative macrophage activation. BMC Immunol., 13, 2012, 31.
18. Gonzalez-Nunez, M., Munoz-Felix, J.M., Lopez-Novoa, J.M., The ALK-1/Smad1 pathway in cardiovascular physiopathology. A new target for therapy?. Biochim. Biophys. Acta 1832 (2013), 1492–1510.
19. Goumans, M.J., Valdimarsdottir, G., Itoh, S., Rosendahl, A., Sideras, P., ten Dijke, P., Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors. EMBO J. 21 (2002), 1743–1753.
20. Goumans, M.J., Valdimarsdottir, G., Itoh, S., Lebrin, F., Larsson, J., Mummery, C., Karlsson, S., ten Dijke, P., Activin receptor-like kinase (ALK) 1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling. Mol.Cell 12 (2003), 817–828.
21. Gratchev, A., Kzhyshkowska, J., Kannookadan, S., et al. Activation of a TGF-beta-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-beta receptor II. J. Immunol. 180 (2008), 6553–6565.
22. Grotendorst, G.R., Smale, G., Pencev, D., Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils. J. Cell Physiol. 140 (1989), 396–402.
23. Guo, X., Wang, X.F., Signaling cross-talk between TGF-beta/BMP and other pathways. Cell Res. 19 (2009), 71–88.
24. Hannan, N.R., Jamshidi, P., Pera, M.F., Wolvetang, E.J., BMP-11 and myostatin support undifferentiated growth of human embryonic stem cells in feeder-free cultures. Cloning Stem Cells 11 (2009), 427–435.
25. Harpel, J.G., Metz, C.N., Kojima, S., Rifkin, D.B., Control of transforming growth factor-beta activity: latency vs. activation. Prog. Growth Factor Res. 4 (1992), 321–335.
26. Hong, J.H., Lee, G.T., Lee, J.H., Kwon, S.J., Park, S.H., Kim, S.J., Kim, I.Y., Effect of bone morphogenetic protein-6 on macrophages. Immunology 128 (2009), e442–450.
27. Hussell, T., Bell, T.J., Alveolar macrophages: plasticity in a tissue-specific context. Nat. Rev. Immunol. 14 (2014), 81–93.
28. Imamura, T., Takase, M., Nishihara, A., Oeda, E., Hanai, J., Kawabata, M., Miyazono, K., Smad6 inhibits signalling by the TGF-beta superfamily. Nature 389 (1997), 622–626.
29. Inoue, Y., Imamura, T., Regulation of TGF-beta family signaling by E3 ubiquitin ligases. Cancer Sci. 99 (2008), 2107–2112.
30. Jiang, W.G., Douglas-Jones, A.G., Mansel, R.E., Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer. Prostaglandins Leukot. Essent. Fatty Acids 74 (2006), 125–134.
31. Kim, J.H., Seo, G.Y., Kim, P.H., Activin A Stimulates Mouse APCs to Express BAFF via ALK4-Smad3 Pathway. Immune Netw. 11 (2011), 196–202.
32. Lebrin, F., Goumans, M.J., Jonker, L., Carvalho, R.L., Valdimarsdottir, G., Thorikay, M., Mummery, C., Arthur, H.M., ten Dijke, P., Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction. EMBO J. 23 (2004), 4018–4028.
33. Liu, X., Yue, J., Frey, R.S., Zhu, Q., Mulder, K.M., Transforming growth factor beta signaling through Smad1 in human breast cancer cells. Cancer Res. 58 (1998), 4752–4757.
34. Makatsori, E., Lamari, F.N., Theocharis, A.D., Anagnostides, S., Hjerpe, A., Tsegenidis, T., Karamanos, N.K., Large matrix proteoglycans, versican and perlecan: are expressed and secreted by human leukemic monocytes. Anticancer Res. 23 (2003), 3303–3309.
35. Mantovani, A., Sozzani, S., Locati, M., Allavena, P., Sica, A., Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 23 (2002), 549–555.
36. Massague, J., TGF-beta signal transduction. Annu. Rev. Biochem. 67 (1998), 753–791.
37. Massague, J., Seoane, J., Wotton, D., Smad transcription factors. Genes Dev. 19 (2005), 2783–2810.
38. McCartney-Francis, N., Mizel, D., Wong, H., Wahl, L., Wahl, S., TGF-beta regulates production of growth factors and TGF-beta by human peripheral blood monocytes. Growth Factors 4 (1990), 27–35.
39. McCartney-Francis, N.L., Wahl, S.M., Transforming growth factor beta: a matter of life and death. J. Leukoc. Biol. 55 (1994), 401–409.
40. Meng, Y., Chen, C., Wang, L., Wang, X., Tian, C., Du, J., Li, H.H., Toll-like receptor-2 ligand peptidoglycan upregulates expression and ubiquitin ligase activity of CHIP through JNK pathway. Cell Physiol. Biochem. 32 (2013), 1097–1105.
41. Moustakas, A., Smad signalling network. J. Cell Sci. 115 (2002), 3355–3356.
42. Nakamura, R., Kayamori, K., Oue, E., Sakamoto, K., Harada, K., Yamaguchi, A., Transforming growth factor-beta synthesized by stromal cells and cancer cells participates in bone resorption induced by oral squamous cell carcinoma. Biochem. Biophys. Res. Commun. 458 (2015), 777–782.
43. Nakao, A., Afrakhte, M., Moren, A., et al. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389 (1997), 631–635.
44. Nam, E.H., Park, S.R., Kim, P.H., TGF-beta1 induces mouse dendritic cells to express VEGF and its receptor (Flt-1) under hypoxic conditions. Exp. Mol. Med. 42 (2010), 606–613.
45. Oh, S.P., Yeo, C.Y., Lee, Y., Schrewe, H., Whitman, M., Li, E., Activin type IIA and IIB receptors mediate Gdf11 signaling in axial vertebral patterning. Genes Dev. 16 (2002), 2749–2754.
46. Oh, S.P., Seki, T., Goss, K.A., et al. Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 97 (2000), 2626–2631.
47. Pardali, E., Goumans, M.J., Ten Dijke, P., Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell Biol. 20 (2010), 556–567.
48. Pasini, F.S., Zilberstein, B., Snitcovsky, I., et al. A gene expression profile related to immune dampening in the tumor microenvironment is associated with poor prognosis in gastric adenocarcinoma. J. Gastroenterol. 49 (2014), 1453–1466.
49. Rebbapragada, A., Benchabane, H., Wrana, J.L., Celeste, A.J., Attisano, L., Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol. Cell. Biol. 23 (2003), 7230–7242.
50. Sanz-Rodriguez, F., Fernandez, L.A., Zarrabeitia, R., Perez-Molino, A., Ramirez, J.R., Coto, E., Bernabeu, C., Botella, L.M., Mutation analysis in Spanish patients with hereditary hemorrhagic telangiectasia: deficient endoglin up-regulation in activated monocytes. Clin. Chem. 50 (2004), 2003–2011.
51. Schultz-Cherry, S., Murphy-Ullrich, J.E., Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism. J. Cell Biol. 122 (1993), 923–932.
52. Shen, Z., Kauttu, T., Seppanen, H., Vainionpaa, S., Ye, Y., Wang, S., Mustonen, H., Puolakkainen, P., Both macrophages and hypoxia play critical role in regulating invasion of gastric cancer in vitro. Acta Oncol. 52 (2013), 852–860.
53. Shi, Y., Massague, J., Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113 (2003), 685–700.
54. Standiford, T.J., Kuick, R., Bhan, U., Chen, J., Newstead, M., Keshamouni, V.G., TGF-beta-induced IRAK-M expression in tumor-associated macrophages regulates lung tumor growth. Oncogene 30 (2011), 2475–2484.
55. Stohr, R., Mavilio, M., Marino, A., Casagrande, V., Kappel, B., Mollmann, J., Menghini, R., Melino, G., Federici, M., ITCH modulates SIRT6 and SREBP2 to influence lipid metabolism and atherosclerosis in ApoE null mice. Sci. Rep., 5, 2015, 9023.
56. Ten Dijke, P., Goumans, M.J., Itoh, F., Itoh, S., Regulation of cell proliferation by Smad proteins. J. Cell Physiol. 191 (2002), 1–16.
57. Tian, F., Zhou, A.X., Smits, A.M., Larsson, E., Goumans, M.J., Heldin, C.H., Boren, J., Akyurek, L.M., Endothelial cells are activated during hypoxia via endoglin/ALK-1/SMAD1/5 signaling in vivo and in vitro. Biochem. Biophys. Res. Commun. 392 (2010), 283–288.
58. Tsunawaki, S., Sporn, M., Ding, A., Nathan, C., Deactivation of macrophages by transforming growth factor-beta. Nature 334 (1988), 260–262.
59. Van Geest, R.J., Klaassen, I., Vogels, I.M., Van Noorden, C.J., Schlingemann, R.O., Differential TGF-{beta} signaling in retinal vascular cells: a role in diabetic retinopathy?. Invest. Ophthalmol. Vis. Sci. 51 (2010), 1857–1865.
60. Wahl, S.M., Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure. J. Clin. Immunol. 12 (1992), 61–74.
61. Wahl, S.M., Hunt, D.A., Wakefield, L.M., McCartney-Francis, N., Wahl, L.M., Roberts, A.B., Sporn, M.B., Transforming growth factor type beta induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. U. S. A. 84 (1987), 5788–5792.
62. Wang, X., Qian, Y., Jin, R., Wo, Y., Chen, J., Wang, C., Wang, D., Effects of TRAP-1-like protein (TLP) gene on collagen synthesis induced by TGF-beta/Smad signaling in human dermal fibroblasts. PLoS One, 8, 2013, e55899.
63. Wang, X., Abraham, S., McKenzie, J.A., et al. LRG1 promotes angiogenesis by modulating endothelial TGF-beta signalling. Nature 499 (2013), 306–311.
64. Wang, Y., Inger, M., Jiang, H., Tenenbaum, H., Glogauer, M., CD109 plays a role in osteoclastogenesis. PLoS One, 8, 2013, e61213.
65. Wong, H.L., Welch, G.R., Brandes, M.E., Wahl, S.M., IL-4 antagonizes induction of Fc gamma RIII (CD16) expression by transforming growth factor-beta on human monocytes. J. Immunol. 147 (1991), 1843–1848.
66. Wrighton, K.H., Lin, X., Yu, P.B., Feng, X.H., Transforming Growth Factor {beta} Can Stimulate Smad1 Phosphorylation Independently of Bone Morphogenic Protein Receptors. J. Biol. Chem. 284 (2009), 9755–9763.
67. Yuan, Z., Mehta, H.J., Mohammed, K., Nasreen, N., Roman, R., Brantly, M., Sadikot, R.T., TREM-1 is induced in tumor associated macrophages by cyclo-oxygenase pathway in human non-small cell lung cancer. PLoS One, 9, 2014, e94241.
68. Yue, J., Hartsough, M.T., Frey, R.S., Frielle, T., Mulder, K.M., Cloning and expression of a rat Smad1: regulation by TGFbeta and modulation by the Ras/MEK pathway. J. Cell Physiol. 178 (1999), 387–396.
69. Zamarron, B.F., Chen, W., Dual roles of immune cells and their factors in cancer development and progression. Int. J. Biol. Sci. 7 (2011), 651–658.
70. Zhang, Y.E., Non-Smad pathways in TGF-beta signaling. Cell Res. 19 (2009), 128–139.